𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of everolimus in pancreatic neuroendocrine tumors

✍ Scribed by Goldstein, Robert ;Meyer, Tim

Book ID
118057748
Publisher
Expert Reviews
Year
2011
Tongue
English
Weight
808 KB
Volume
11
Category
Article
ISSN
1473-7140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Everolimus for Advanced Pancreatic Neuro
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
✍ Yao, James C.; Shah, Manisha H.; Ito, Tetsuhide; Bohas, Catherine Lombard; Wolin πŸ“‚ Article πŸ“… 2011 πŸ› Massachusetts Medical Society 🌐 English βš– 667 KB

## Background: Everolimus, an oral inhibitor of mammalian target of rapamycin (mtor), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. we evaluated the agent in a prospective, randomized, phase 3 study. ## Methods: We randomly assign

Sunitinib in pancreatic neuroendocrine t
Sunitinib in pancreatic neuroendocrine tumors
✍ Eric Raymond, Pascal Hammel, Chantal Dreyer, Christian Maatescu, Olivia Hentic, πŸ“‚ Article πŸ“… 2012 πŸ› Springer-Verlag 🌐 English βš– 269 KB